Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.32 EUR | +3.56% | +3.90% | -17.95% |
Apr. 04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.95% | 13.79M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+46.68% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Celyad Oncology : HC Wainwright Adjusts Celyad Oncology's Price Target to $18 From $22, Keeps Buy Rating